Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No wonder then

No wonder then

posted on Mar 19, 2009 09:10AM

that RG mentioned recently in one of his letters to shareholders that PTSC was looking for revenues outside of the MMP portfolio. When I first read it I was a bit intrigued since this company IS about MMP and little else. For RG to change the game this late meant that they expected the patents to be declared null and void. Now, what can really go wrong here are the flood of lawsuits from companies that have already licensed this portfolio.

Share
New Message
Please login to post a reply